Cardion

About:

Cardion is a biopharmaceutical company that develops cardiovascular gene therapy products.

Top Investors: ITX Corporation, IKB Deutsche Industriebank, Techno Venture Management, Deutsche Venture Capital, Mulligan BioCapital

Description:

Cardion is a biopharmaceutical company that integrates synergistic local gene delivery, stem cell engineering, and tolerance induction capabilities to build cardiovascular gene therapy products. Cardion was founded in 1996 and is based in Erkrath, Nordrhein-Westfalen.

Total Funding Amount:

11.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Erkrath, Nordrhein-Westfalen, Germany

Founded Date:

1996-01-01

Contact Email:

info(AT)cardion-ag.de

Founders:

Jurgen Schrader

Number of Employees:

11-50

Last Funding Date:

2002-09-23

IPO Status:

Private

Industries: